Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance) - Concepedia

Concepedia

Publication | Closed Access

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

231

Citations

15

References

2013

Year

Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil, Louis Fehrenbacher, Kathleen Flynn, Pamela J. Atherton, Drew K. Seisler, Rubina Qamar, Grant Lewis, Axel Grothey

Journal of Clinical Oncology

Abstract

This study does not support using calcium/magnesium to protect against oxaliplatin-induced neurotoxicity.

References

	Year	Citations

Page 1